NFT: Test, Amphetamine, Over The Counter
What it covers
An amphetamine test system is a device intended to measure amphetamine, a central nervous system stimulating drug, in plasma and urine. Measurements obtained by this device are used in the diagnosis and treatment of amphetamine use or overdose and in monitoring levels of amphetamine to ensure appropriate therapy.
The identification in 21 CFR 862.3100, amphetamine test system. FDA gives NFT no definition of its own, so the regulation’s describes it.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K261409 | BioTeke® Multi-Drug Urine Test Cup | Bioteke Corporation (Wuxi) Co., Ltd. | Sep 10, 2026 | Traditional |
| K261984 | AssureTech Quick Cup Tests;AssureTech Multi-drug Urine Test Cup | Assure Tech., LLC | Jul 17, 2026 | Traditional |
| K261280 | BioSieve Multi-Drug Urine Test Panel;BioSieve Multi-Drug Urine Home Test Panel | Vivachek Biotech (Hangzhou) Co., Ltd. | May 22, 2026 | Traditional |
| K260065 | SAFElife T-Dip Multi-Drug Urine Test Panel; SAFElife T-Dip Multi-Drug Urine Test Panel Dx | Guangzhou Wondfo Biotech Co., Ltd. | Apr 28, 2026 | Traditional |
| K260355 | Webest Multi-Drug Urine Cup; Webest Home Multi-Drug Urine Cup | WEBEST Biotech,, LLC | Mar 9, 2026 | Traditional |
| K252550 | SAFElife T-Cup Multi-Drug Urine Test Cup; SAFElife T-Cup Multi-Drug Urine Test Cup Dx | Guangzhou Wondfo Biotech Co., Ltd. | Nov 18, 2025 | Traditional |
| K252867 | VINScreen Urine Drug Test Cup; VINScreen Urine Drug Home Test Cup | Advin Biotech, Inc. | Oct 9, 2025 | Traditional |
| K252554 | Wisdiag Multi-Drug Urine Test Cup; Wisdiag Multi-Drug Urine Home Test Cup | Vivachek Biotech (Hangzhou) Co., Ltd. | Sep 12, 2025 | Traditional |
| K252118 | CLUNGENE Multi-Drug Test Easy Cup; CLUNGENE Multi-Drug Home Test Easy Cup | Hangzhou Clongene Biotech Co., Ltd. | Aug 27, 2025 | Traditional |
| K252259 | AssureTech Quick Cup Tests; AssureTech Multi-drug Urine Test Cup | Assure Tech., LLC | Aug 15, 2025 | Traditional |
Clearances by year
32 NFT 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 5 | 35 |
| 2025 | 8 | 37 |
| 2024 | 4 | 31 |
| 2023 | 1 | 37 |
| 2022 | 3 | 63 |
| 2021 | 1 | 209 |
| 2020 | 2 | 26 |
| 2019 | 1 | 29 |
| 2018 | 6 | 56 |
| 2017 | 1 | 117 |
Who submits
15 applicants cleared a NFT device since 2011. 69% of the clearances went to applicants in China, then United States (25%) and Canada (6%). By type: Traditional 100%.
| Applicant | Clearances since 2011 |
|---|---|
| Guangzhou Wondfo Biotech Co., Ltd. | 4 |
| Hangzhou AllTest Biotech Co., Ltd. | 4 |
| Vivachek Biotech (Hangzhou) Co., Ltd. | 4 |
| Assure Tech. (Hangzhou) Co, Ltd. | 3 |
| Assure Tech., LLC | 3 |
| Safecare Biotech (Hangzhou) Co., Ltd. | 3 |
| Aicheck Biotech, Inc. | 2 |
| Healstone Biotech, Inc. | 2 |
How FDA classifies it
Class II (special controls). An amphetamine test system is not exempt if it is intended for any use other than employment or insurance testing. The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9, provided the test system is intended for employment and insurance testing and includes a statement in the labeling that the device is intended solely for use in employment and insurance testing.
From 21 CFR 862.3100. Special controls are the requirements a 510(k) must show it meets.
Standards
21 CFR 862.3100 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent NFT clearances declared.
Ask about NFT
Questions about NFT
What is FDA product code NFT?
Product code NFT, “Test, Amphetamine, Over The Counter” in FDA's classification database, is a Class II device type under 21 CFR 862.3100 (amphetamine test system), reviewed by FDA's Clinical Toxicology panel. FDA's 510(k) database lists 32 clearances under NFT, 32 of them since 2011.
How many 510(k) clearances are there under NFT?
FDA’s 510(k) database listed 32 clearances under NFT as of Oct 29, 2026, 32 of them decided since 2011; the most recent decision was Sep 10, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a NFT 510(k)?
For the 13 NFT clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 35 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most NFT clearances?
Since 2011: Guangzhou Wondfo Biotech Co., Ltd. (4), Hangzhou AllTest Biotech Co., Ltd. (4), Vivachek Biotech (Hangzhou) Co., Ltd. (4), Assure Tech. (Hangzhou) Co, Ltd. (3) and Assure Tech., LLC (3). 15 applicants have cleared a NFT device in that time.